News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Guenther Sven
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2023 |
4
| Guenther Sven (Chief Scientific Officer) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 306,000 options to buy
@ $4.54, valued at
$1.4M
|
|
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Guenther Sven (EVP, Research & Development) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 160,000 options to buy
@ $0.374, valued at
$59.8k
|
|
| 11/27/2019 |
4
| Guenther Sven (EVP, Research & Development) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 56,000 options to buy
@ $0.5161, valued at
$28.9k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2018 |
4
| Guenther Sven (EVP, Research & Development) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 75,000 options to buy
@ $5.5, valued at
$412.5k
|
|
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|